Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

ClinicalTrials.gov ID: NCT00049400

Public ClinicalTrials.gov record NCT00049400. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Pharmacokinetic Study Of Epothilone B Analogue BMS-247550 (NSC 710428D) In Patients With Advanced Malignancies And Varying Levels Of Liver Dysfunction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase I trial is studying the side effects and best dose of ixabepilone in treating patients with advanced solid tumors or lymphomas and liver dysfunction.

Study identification

NCT ID
NCT00049400
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
78 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2003 (Type not available)
Primary completion
Sep 2006 (Actual)
Completion
Dec 2007 (Actual)
Last update posted
Apr 3, 2015

2003 – 2007

United States locations

U.S. sites
23
U.S. states
6
U.S. cities
18
Facility City State ZIP Site status
City of Hope Comprehensive Cancer Center Duarte California 91010-3000 —
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90089-9181 —
University of California Davis Cancer Center Sacramento California 95817 —
Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood Illinois 60153 —
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Kansas 66160-7357 —
Case Comprehensive Cancer Center Cleveland Ohio 44106 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Community Oncology Group at Cleveland Clinic Cancer Center Independence Ohio 44131 —
Cleveland Clinic - Wooster Wooster Ohio 44691 —
Brooke Army Medical Center Fort Sam Houston Texas 78234 —
Wilford Hall Medical Center Lackland Air Force Base Texas 78236 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3900 —
St. Joseph Hospital Community Cancer Center Bellingham Washington 98225 —
Olympic Hematology and Oncology Bremerton Washington 98310 —
Skagit Valley Hospital Cancer Care Center Mount Vernon Washington 98273 —
Group Health Central Hospital Seattle Washington 98104-1387 —
Fred Hutchinson Cancer Research Center Seattle Washington 98104 —
Harborview Medical Center Seattle Washington 98104 —
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington 98122-4307 —
University Cancer Center at University of Washington Medical Center Seattle Washington 98195-6043 —
North Puget Oncology at United General Hospital Sedro-Woolley Washington 98284 —
Cancer Care Northwest - Spokane South Spokane Washington 99202 —
Wenatchee Valley Medical Center Wenatchee Washington 98801-2028 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00049400, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 3, 2015 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00049400 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →